Short Interest in Avalon GloboCare Corp. (NASDAQ:ALBT) Expands By 120.1%

Avalon GloboCare Corp. (NASDAQ:ALBT) was the recipient of a significant growth in short interest in June. As of June 15th, there was short interest totalling 202,900 shares, a growth of 120.1% from the May 31st total of 92,200 shares. Based on an average daily trading volume, of 2,760,000 shares, the short-interest ratio is currently 0.1 days. Currently, 4.5% of the shares of the stock are short sold.

Avalon GloboCare Stock Performance

NASDAQ ALBT opened at $0.47 on Friday. Avalon GloboCare has a fifty-two week low of $0.24 and a fifty-two week high of $1.70. The stock has a market cap of $5.22 million, a PE ratio of -0.33 and a beta of 0.30. The firm’s fifty day moving average price is $0.38 and its two-hundred day moving average price is $0.39.

Avalon GloboCare (NASDAQ:ALBT) last issued its quarterly earnings data on Thursday, May 30th. The company reported ($0.12) earnings per share for the quarter. The company had revenue of $0.32 million during the quarter.

Avalon GloboCare Company Profile

Avalon GloboCare Corp., together with its subsidiaries, owns and operates commercial real estate properties in the United States and China. The company develops and delivers transformative cellular therapeutics, precision diagnostics, and clinical laboratory services. Its leading candidates are AVA-001, an anti-CD19 CAR-T, which has completed first-in-human clinical trial for relapsed/refractory (R/R) B-cell lymphoblastic leukemia; and AVA-011 that has completed pre-clinical laboratory studies and undergoing IND-enabling process development stage to generate cGMP-grade AVA-011 CAR-T cells.